Trial Site Detail

 

Drug:
Pembrolizumab + Cyclophosphamide
Trial:
Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial (PEMBROSARC)
Conditions: Sarcoma
Trial Status:
Active, not recruiting

 

Institut Claudius Regaud

     
Toulouse , 31052
France

 

Principal Investigator:
Christine Chevreau
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Institut Claudius Regaud Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.